title: Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
abstract: BACKGROUND
  The aim of this study was to investigate the differential expression of markers related to metabolic, mitochondrial and autophagy status in different molecular subtypes of breast cancer.
  
  
  METHODS
  Using tissue microarray sections generated from 740 cases of breast cancer, we performed immunohistochemical staining for Glut-1, CAIX, MCT4, ATP synthase, glutaminase, BNIP3, Beclin-1, LC3A, LC3B and p62. Based on the immunohistochemical expression of estrogen receptor (ER), progesterone (PR), HER2, and Ki-67 labeling index, the cases were classified into luminal A, luminal B, HER2 and triple-negative breast cancer (TNBC). We further classified metabolic phenotypes of tumors according to glycolytic status by assessing Glut-1 and CAIX expression as follows: Warburg type: tumor (glycolysis type), stroma (nonglycolysis type); reverse Warburg type: tumor (nonglycolysis type), stroma (glycolysis type); mixed type: tumor (glycolysis type), stroma (glycolysis type); and null type: tumor (nonglycolysis type), stroma (nonglycolysis type).
  
  
  RESULTS
  Expression of Glut-1, MCT4 and LC3A was highest in TNBC and lowest in luminal A type (P < 0.001). Tumors were classified into 298 Warburg type (40.3%), 54 reverse Warburg type (7.3%), 62 mixed type (8.4%) and 326 null type (44.0%). The mixed type had a higher histologic grade, ER negativity, PR negativity and Ki-67 index, whereas the null type showed lower histologic grade, ER positivity, PR positivity and Ki-67 index (P < 0.001). TNBC constituted the major portion of Warburg and mixed types, and luminal A consisted mainly of reverse Warburg and null types (P < 0.001).
  
  
  CONCLUSIONS
  Breast cancer is heterogeneous in its metabolic status, and therefore it can be classified into various metabolic phenotypes. Specifically, the Warburg and mixed types had strong associations with TNBC, whereas reverse the Warburg and null types had associations with the luminal type, suggesting a correlation between metabolic phenotype and the biology of breast cancer.
authors.forename: Junjeong
authors.initials: J
authors.lastname: Choi
authors.forename: Do Hee
authors.initials: DH
authors.lastname: Kim
authors.forename: Woo Hee
authors.initials: WH
authors.lastname: Jung
authors.forename: Ja Seung
authors.initials: JS
authors.lastname: Koo
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D060787:Neoplasm Grading; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010641:Phenotype; D020543:Proteome; D017154:Stromal Cells / Q000378:metabolism* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D020543:Proteome
references.citation: Tumour Biol. 2012 Jun;33(3):787-98
references.pmid: 22203494
references.citation: Histol Histopathol. 2011 Oct;26(10):1279-86
references.pmid: 21870331
references.citation: Mol Cell Biol. 2009 May;29(10):2570-81
references.pmid: 19273585
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: J Clin Oncol. 2008 May 20;26(15):2473-81
references.pmid: 18487567
references.citation: Ann Oncol. 2011 Aug;22(8):1736-47
references.pmid: 21709140
references.citation: Cell Cycle. 2010 Jun 1;9(11):2201-19
references.pmid: 20519932
references.citation: FEBS J. 2007 Mar;274(6):1393-418
references.pmid: 17302740
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: J Clin Oncol. 2007 Jan 1;25(1):118-45
references.pmid: 17159189
references.citation: Am J Surg. 2009 Feb;197(2):266-9
references.pmid: 18614146
references.citation: Breast Cancer Res Treat. 2012 Aug;134(3):957-67
references.pmid: 22370627
references.citation: J Clin Oncol. 2010 Jun 1;28(16):2784-95
references.pmid: 20404251
references.citation: Cell Cycle. 2010 Aug 15;9(16):3256-76
references.pmid: 20814239
references.citation: Cell Cycle. 2010 Sep 1;9(17):3506-14
references.pmid: 20818174
references.citation: Histopathology. 2008 Jan;52(1):108-18
references.pmid: 18171422
references.citation: J Biol Chem. 2008 Apr 18;283(16):10892-903
references.pmid: 18281291
references.citation: Clin Breast Cancer. 2006 Jun;7(2):153-7
references.pmid: 16800975
references.citation: Cell Cycle. 2009 Dec;8(23):3984-4001
references.pmid: 19923890
references.citation: Histopathology. 1991 Nov;19(5):403-10
references.pmid: 1757079
references.citation: Cell Cycle. 2010 Sep 1;9(17):3515-33
references.pmid: 20855962
references.citation: Cell Cycle. 2010 Jun 15;9(12):2423-33
references.pmid: 20562526
references.citation: Lab Invest. 2000 Dec;80(12):1943-9
references.pmid: 11140706
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: Biochem Biophys Res Commun. 2004 Jan 16;313(3):459-65
references.pmid: 14697210